These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations]. Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550 [TBL] [Abstract][Full Text] [Related]
7. The clinician through the looking glass: sputum microbiology in COPD exacerbations. Bouros D; Pneumatikos I Respiration; 2007; 74(1):13-4. PubMed ID: 16888368 [No Abstract] [Full Text] [Related]
8. [Comparative study of the antibiogram of primary and subcultures in diagnosing acute bronchopulmonary infections]. Buiuc D; Burcoveanu C Rev Med Chir Soc Med Nat Iasi; 1984; 88(4):663-8. PubMed ID: 6537634 [No Abstract] [Full Text] [Related]
9. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Soler N; Agustí C; Angrill J; Puig De la Bellacasa J; Torres A Thorax; 2007 Jan; 62(1):29-35. PubMed ID: 16928715 [TBL] [Abstract][Full Text] [Related]
10. Induced sputum as a diagnostic tactic in pulmonary diseases. Fireman E Isr Med Assoc J; 2003 Jul; 5(7):524-7. PubMed ID: 12901253 [TBL] [Abstract][Full Text] [Related]
12. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639 [TBL] [Abstract][Full Text] [Related]
13. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Miravitlles M Respir Med; 2011 Aug; 105(8):1118-28. PubMed ID: 21353517 [TBL] [Abstract][Full Text] [Related]
14. [Exacerbations of chronic obstructive pulmonary disease and the role of sputum bacteriological examination]. Noweta K; Frankowska M; Grzelewska-Rzymowska I Pneumonol Alergol Pol; 2006; 74(4):396-402. PubMed ID: 17427149 [TBL] [Abstract][Full Text] [Related]
15. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610 [TBL] [Abstract][Full Text] [Related]
16. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Roche N; Kouassi B; Rabbat A; Mounedji A; Lorut C; Huchon G Respiration; 2007; 74(1):19-25. PubMed ID: 16675894 [TBL] [Abstract][Full Text] [Related]
17. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data. Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191 [TBL] [Abstract][Full Text] [Related]
18. Induced sputum: a window to lung pathology. Nicholas B; Djukanović R Biochem Soc Trans; 2009 Aug; 37(Pt 4):868-72. PubMed ID: 19614609 [TBL] [Abstract][Full Text] [Related]
19. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Sethi S Proc Am Thorac Soc; 2004; 1(2):109-14. PubMed ID: 16113422 [TBL] [Abstract][Full Text] [Related]
20. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Patel IS; Vlahos I; Wilkinson TM; Lloyd-Owen SJ; Donaldson GC; Wilks M; Reznek RH; Wedzicha JA Am J Respir Crit Care Med; 2004 Aug; 170(4):400-7. PubMed ID: 15130905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]